Improve the Quality of Care in Patients With Orthopaedic Disorders

Overview

The main objective of the investigators is to improve the quality of care in patients with orthopedic disorders followed in St Luc hospital (Brussels Belgium). To do this, the investigators want to assess the impact of Orthopedic treatments at the structural level (bone structure, muscle, etc.), at the functional level (mobility, strength, stiffness…), on the restriction of activities of patients (walking, make its care daily..) and on the limitation of participation in the life of every day (sport, work, social life, cultural…). This functional evaluation of patients with orthopedic disorders by the ICF model is an original approach rarely used in muscular-skeletal impairments that can very improve the management of these patients and their quality of life. In addition, the investigators associate the harvesting of all medical and computer data collected by high-precision tools in the surgical treatments, to better define the surgical precision and improve the quality of surgical care.

Full Title of Study: “How to Improve the Quality of Care in Patients With Orthopaedic Disorders? – by Using the ICF in All Patients After Conservative or Surgical Treatment. – Through the Creation of an International Norm to Improve the Surgical Precision”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 2021

Detailed Description

The investigators will recruit patients with orthopedic disorders on voluntary basis through department in St Luc Hospital in Brussels, old of 0 to 90 years, men and women with muscular-skeletal impairments (arthrosis, bone or muscle injury, ….). The investigators will exclude patients with multiple pathologies or not able to understand the instructions. They thus impropre the effectiveness of the treatment in Orthopaedics by better defining the route of most effective surgical first for the patient in arthroplasty (mini invasive, posterior, anterior), the most appropriate knee prosthesis type (design of prothesis), the conservative treatment properly to improve the quality of life of patients with orthopedic disorders (plaster, brace, physiotherapy…). They will evaluate the impact of treatments at the structural level (bone structure, muscle, etc.), at the functional level (mobility, strength, stiffness…), on the restriction of activities of patients (walking, make its care daily..) and on the limitation of participation in the life of every day (sport, work, social life, cultural…) following the ICF-WHO model.

In addition, they will dispose of data necessary to better define the surgical precision (international organization for standardization ISO Norm), the quality of surgical care by analyzing data collected by high-precision tools at the surgical treatments.

Patients will be subject to different clinical assessments, fill out questionnaires or come to the laboratory for analysis of the movement depending on the goal defined for each patient. Patients will have their current clinical follow-up (RX, scanner, mobility, force measurement, stiffness…) which the investigators be able to join a quantified analysis of the movement in the laboratory, satisfaction questionnaires, questionnaires measuring the impact of treatment on quality of life and their restriction of activities. It is a broad-spectrum study to try to improve the quality of care within a service target of orthopedics.

Interventions

  • Procedure: orthopedic
    • Compare the type of treatment chosen by the orthopedist with a functional assessment (ICF-WHO model)

Arms, Groups and Cohorts

  • patients with orthopedic disorders
    • Patients with muscular skeletal impairments receiving a treatment (A, B, C…). The investigators compare these treatments (A, B, C…) in function of ICF model in order to improve the quality of care in orthopedic department.

Clinical Trial Outcome Measures

Primary Measures

  • activities
    • Time Frame: 6 months
    • improve the gait; improve the daily activities (washing, eating, dressing…)

Secondary Measures

  • Impairment: ICF domain
    • Time Frame: 6 months
    • force, stiffness, mobility, dexterity
  • participation: ICF domain
    • Time Frame: 6 months
    • effect of treatment on Sports, work, cultural and associative life

Participating in This Clinical Trial

Inclusion Criteria

  • all patients with orthopedic disorders : muscular skeletal impairment

Exclusion Criteria

Dementia patients with multiple disorders Patients who do not understand the instructions

Gender Eligibility: All

Minimum Age: 1 Year

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Cliniques universitaires Saint-Luc- Université Catholique de Louvain
  • Collaborator
    • Orthopeadic team in Saint-luc Hospital Brussels
  • Provider of Information About this Clinical Study
    • Principal Investigator: Detrembleur, Professor – Cliniques universitaires Saint-Luc- Université Catholique de Louvain
  • Overall Official(s)
    • Olivier Cornu, MD,PhD, Principal Investigator, Cliniques universitaires St Luc Brussels

Citations Reporting on Results

Caty GD, Detrembleur C, Bleyenheuft C, Deltombe T, Lejeune TM. Effect of upper limb botulinum toxin injections on impairment, activity, participation, and quality of life among stroke patients. Stroke. 2009 Jul;40(7):2589-91. doi: 10.1161/STROKEAHA.108.544346. Epub 2009 Apr 30.

Bollens B, Gustin T, Stoquart G, Detrembleur C, Lejeune T, Deltombe T. A randomized controlled trial of selective neurotomy versus botulinum toxin for spastic equinovarus foot after stroke. Neurorehabil Neural Repair. 2013 Oct;27(8):695-703. doi: 10.1177/1545968313491002. Epub 2013 Jun 10.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.